NO175133C - Fremgangsmåte for fremstilling av et legemiddelpreparat med findelte 2-fenyl-1,2-benzisoselenazol-3(2H)-on - Google Patents

Fremgangsmåte for fremstilling av et legemiddelpreparat med findelte 2-fenyl-1,2-benzisoselenazol-3(2H)-on

Info

Publication number
NO175133C
NO175133C NO882615A NO882615A NO175133C NO 175133 C NO175133 C NO 175133C NO 882615 A NO882615 A NO 882615A NO 882615 A NO882615 A NO 882615A NO 175133 C NO175133 C NO 175133C
Authority
NO
Norway
Prior art keywords
preparation
benzisoselenazol
phenyl
finely divided
drug
Prior art date
Application number
NO882615A
Other languages
English (en)
Norwegian (no)
Other versions
NO882615L (no
NO175133B (no
NO882615D0 (no
Inventor
Axel Romer
Jurgen Seidel
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of NO882615D0 publication Critical patent/NO882615D0/no
Publication of NO882615L publication Critical patent/NO882615L/no
Publication of NO175133B publication Critical patent/NO175133B/no
Publication of NO175133C publication Critical patent/NO175133C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO882615A 1987-06-20 1988-06-14 Fremgangsmåte for fremstilling av et legemiddelpreparat med findelte 2-fenyl-1,2-benzisoselenazol-3(2H)-on NO175133C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720493 DE3720493A1 (de) 1987-06-20 1987-06-20 Arzneizubereitungen mit mikronisierten ebselen-kristallen

Publications (4)

Publication Number Publication Date
NO882615D0 NO882615D0 (no) 1988-06-14
NO882615L NO882615L (no) 1988-12-21
NO175133B NO175133B (no) 1994-05-30
NO175133C true NO175133C (no) 1994-09-07

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882615A NO175133C (no) 1987-06-20 1988-06-14 Fremgangsmåte for fremstilling av et legemiddelpreparat med findelte 2-fenyl-1,2-benzisoselenazol-3(2H)-on

Country Status (25)

Country Link
US (1) US5021242A (lt)
EP (1) EP0296389B1 (lt)
JP (1) JPH0713016B2 (lt)
KR (1) KR970005322B1 (lt)
AT (1) ATE69165T1 (lt)
AU (1) AU603454B2 (lt)
CA (1) CA1310906C (lt)
DD (1) DD271056A5 (lt)
DE (2) DE3720493A1 (lt)
DK (1) DK173628B1 (lt)
ES (1) ES2041736T3 (lt)
FI (1) FI88256C (lt)
GE (1) GEP19960342B (lt)
GR (1) GR3003084T3 (lt)
HU (1) HU200096B (lt)
IE (1) IE63512B1 (lt)
LT (1) LT3669B (lt)
LV (1) LV10381B (lt)
MX (1) MX169170B (lt)
NO (1) NO175133C (lt)
NZ (1) NZ225066A (lt)
PT (1) PT87767B (lt)
RU (1) RU1834657C (lt)
UA (1) UA12648A (lt)
ZA (1) ZA884025B (lt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
ES2145065T3 (es) * 1993-10-27 2000-07-01 Daiichi Seiyaku Co Preparacion granular.
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
DK0812195T3 (da) * 1995-02-28 2003-03-03 Aventis Pharma Inc Farmaceutisk sammensætning til piperidinoalkanolforbindelser
JP4344405B2 (ja) * 1997-08-26 2009-10-14 アベンティス・ファーマスーティカルズ・インコーポレイテッド ピペリジノアルカノール−鬱血除去剤の組合せ用医薬組成物
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
AU3457300A (en) 1999-03-31 2000-10-16 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
MXPA05008088A (es) * 2003-02-24 2005-09-21 Mallinckrodt Inc Proceso mejorado para preparar benzhidril tioacetamida.
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
US20080293777A1 (en) * 2007-05-23 2008-11-27 Erlanson Daniel A Weight Loss Treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) * 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen

Also Published As

Publication number Publication date
DE3720493A1 (de) 1989-01-26
HU200096B (en) 1990-04-28
ZA884025B (en) 1988-12-20
GR3003084T3 (en) 1993-02-17
DK173628B1 (da) 2001-05-07
LV10381B (en) 1995-06-20
LV10381A (lv) 1995-02-20
ATE69165T1 (de) 1991-11-15
DD271056A5 (de) 1989-08-23
KR970005322B1 (ko) 1997-04-15
LT3669B (en) 1996-01-25
IE63512B1 (en) 1995-05-03
NO882615L (no) 1988-12-21
FI882912L (fi) 1988-12-21
ES2041736T3 (es) 1996-07-16
JPH0713016B2 (ja) 1995-02-15
FI88256C (fi) 1993-04-26
RU1834657C (ru) 1993-08-15
DK333388A (da) 1988-12-21
NZ225066A (en) 1990-07-26
DE3866033D1 (de) 1991-12-12
LTIP903A (en) 1995-03-27
JPH01100125A (ja) 1989-04-18
US5021242A (en) 1991-06-04
HUT50037A (en) 1989-12-28
FI882912A0 (fi) 1988-06-17
DK333388D0 (da) 1988-06-17
NO175133B (no) 1994-05-30
GEP19960342B (en) 1996-02-20
KR890000084A (ko) 1989-03-11
NO882615D0 (no) 1988-06-14
UA12648A (uk) 1997-02-28
EP0296389A1 (de) 1988-12-28
EP0296389B1 (de) 1991-11-06
CA1310906C (en) 1992-12-01
IE881628L (en) 1988-12-20
PT87767B (pt) 1992-10-30
AU603454B2 (en) 1990-11-15
MX169170B (es) 1993-06-23
AU1811688A (en) 1988-12-22
FI88256B (fi) 1993-01-15
PT87767A (pt) 1989-05-31

Similar Documents

Publication Publication Date Title
NO175133C (no) Fremgangsmåte for fremstilling av et legemiddelpreparat med findelte 2-fenyl-1,2-benzisoselenazol-3(2H)-on
HUT43843A (en) Process for production of derivatives of benzimidasole and medical compounds containing thereof
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
JPS5756427A (en) Medicine containing 2-phenyl-1,2-benzisoselenazole- 3(2h)-one
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
PT83610A (en) Process for the preparation of heterocyclic analogs of wevalolactone and derivatives thereofand of pharmaceutical compositions containing them
NO176550C (no) Fremgangsmåte for fremstilling av stabile, pressede, farmasöytiske formuleringer inneholdende en forbindelse
DK324185D0 (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
PT86925A (pt) Process for the preparation of imidazodiazepine derivatives and of pharmaceutical compositions containing the same
DK537889A (da) Parenteral oploesning af 2-phenyl-1,2-benzoisoselenazol-3(h)-on og fremgangsmaade til fremstilling deraf
NO167978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
GR3001463T3 (en) Taurine derivative, its preparation and pharmaceutical compositions containing it
HUT40107A (en) Process for production of derivatives of n-substituated aziridin-2-carbonic acid and medical preparatives containing thereof
ATE12241T1 (de) Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen.
DE2965783D1 (en) Monochlorcitric acid derivatives, pharmaceutical compositions containing them and process for the preparation of these derivatives
AU6740187A (en) Heterocyclic compounds, methods for the manufacture of the same and pharmaceutical compositions containing the same
MY105044A (en) Thieno (3', 4' -4, 5)imidazo(2,1-b)thiazole derivatives, a process for their preparation and their use in medicaments.

Legal Events

Date Code Title Description
MK1K Patent expired